Radiation before surgery for early-stage breast cancer
Part of Cancer, Skin clinical trials.
This trial tests giving radiation to the tumor area before surgery for women with early-stage, hormone-sensitive breast cancer. The idea is to see if giving radiation first can help protect healthy tissue while still being effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 45 years old.
- Your breast cancer is early-stage (tumor smaller than 2.5 cm and no spread to lymph nodes).
- Your cancer type is ER-positive and HER2-negative.
- You haven't had any previous treatment for breast cancer.
- Your tumor is not too close to your skin or chest wall (at least 5 mm away).
- You are able to have a clear picture of your tumor on a CT or MRI scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study gives radiation to the breast before surgery to see if some people can safely delay or even skip surgery. It targets women with a small, node-negative, ER-positive breast cancer with low genetic risk.
This study tests whether giving a single dose of radiation before breast surgery can be safe and effective for early-stage breast cancer. It may help by shrinking or treating the tumor right before the operation, depending on your case.
This study tests whether giving radiation therapy along with standard medical treatment before surgery can improve outcomes for early-stage breast cancer. It aims to see if this combination is safe and effective.
This trial tests a one-time radiation treatment given directly to the area where your breast cancer was removed. It aims to reduce the need for multiple radiation sessions and may be an option for certain patients with early-stage breast cancer.
This trial tests a shorter, focused type of radiation (APBI using SBRT) after lumpectomy for certain early breast cancers. It may help by targeting only the part of the breast where the tumor was, rather than treating the whole breast, while keeping safety and cancer control in mind.
This trial tests a focused radiation treatment before surgery for early-stage breast cancer that is hormone receptor positive and HER2 negative. The goal is to give precise radiation only to the tumor, with the hope of reducing side effects and improving outcomes.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.